Background There are some reports about the antitumor effects of statins in these days.
Statins decrease the level of cholesterol in the blood by inhibiting 3-hydroxy-3-methylglutaryl …

Epidemiological studies have linked statin use with a decreased risk of advanced prostate
cancer and an improved recurrence-free survival after radical therapy. It is unclear, however …

Dyslipidemia and prostate cancer are two of the most common medical conditions affecting
adult males in the USA. In recent years, a large volume of research has focused on …

Cholesterol-lowering treatment has been suggested to delay progression of prostate cancer
by decreasing serum LDL. We studied in vitro the effect of extracellular LDL-cholesterol on …

Statins are cholesterol-lowering drugs that are widely used to prevent and treat
atherosclerotic cardiovascular disease. Recent research from both in vitro and in vivo …

The potential of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ('statins') to
reduce the incidence and/or progression of certain malignancies remains uncertain. Some …

The role of statin therapy in prostate cancer (PCa) prevention and treatment is plagued by
controversy. This critical review of published clinical series reveals several caveats in earlier …

The potential ability of statin medications to prevent cancer has recently received
considerable attention. Of all cancers studied, data for prostate cancer are the most …

The role of statins in preventing prostate cancer is currently a controversial issue. The aim of
this review is to investigate the effects of statins use on prostate cancer risk. Electronic …

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, known as statins, are
commonly prescribed for the treatment of hypercholesterolemia and cardiovascular disease …